This federal contract award is for the delivery of XIFAXAN 550 MG TABLET UD 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,847.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 with a completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 3/11/25, 9:55 AM